Yair Einhorn
@yaireinhorn
Science & Innovation. Special interest in BioTech, Pharma, Gene Editing & CRISPR 🧬. Also sharing my thoughts on the Financial Markets & the Global Economy. 📈
ID: 1238780417324580867
14-03-2020 10:54:12
18,18K Tweet
13,13K Takipçi
46 Takip Edilen
U.S. FDA 4/During #EHA23 CRISPR Therapeutics & $VRTX presented an updated clinical data from both exa-cel trails - #CLIMB-111 (#BetaThalassemia) & CLIMB-121 (#SickleCell) demonstrating that exa-cel has met both primary & secondary endpoints thus strengthening its potential as a one-time cure. 🧵👇